Daniele Moratto

Daniele Moratto

Auto-generated profile, based on publicly available information

Daniele Moratto

Flow Cytometry Unit Clinical Chemistry Laboratory ASST Spedali Civili of Brescia Brescia Italy

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MGMatteo M. Guerrini
Matteo M. Guerrini
CSCristina Sobacchi
Cristina Sobacchi
BCBarbara Cassani
Barbara Cassani
MAMario Abinun
Mario Abinun
SKSara Sebnem Kilic
Sara Sebnem Kilic
AFAnnalisa Frattini
Annalisa Frattini

9 March 2022 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
FSFrancesco Saettini
Francesco Saettini
GFGrazia Fazio
Grazia Fazio
MBMaria Teresa Bonati
Maria Teresa Bonati
DMDaniele Moratto
Daniele Moratto
VALENTINA MASsAVALENTINA MASsA
VALENTINA MASsA
RBRaffaele Badolato
Raffaele Badolato
The Rubinstein–Taybi syndrome (RSTS) is a rare developmental disorder characterized by craniofacial dysmorphisms, broad thumbs and toes, intellectual disability, growth deficiency, and recurrent infections. Mutations in the cyclic adenosine monophosphate response element‐binding protein (CREB)‐binding protein (CREBBP) or in the E1A‐associated protein p300 (EP300) genes have been demonstrated in 55% (RSTS1) and up to 8% of the patients (RSTS2), respectively. Dysfunction of immune response has been reported in a subgroup of individuals with RSTS. Here we characterize two patients carrying the same EP300 variant and distinctive RSTS features (including congenital heart abnormalities, short stature, feeding problems, and gastroesophageal reflux). Whole exome sequencing did not support a dual molecular diagnosis hypothesis. Nonetheless, patients showed distinct clinical manifestations and immunological features. The most severe phenotype was associated with reduced T‐cell production and diversity. This latter feature was confirmed in a control group of four RSTS patients.

4 August 2018 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
FSFrancesco Saettini
Francesco Saettini
DMDaniele Moratto
Daniele Moratto
AGAndrea Grioni
Andrea Grioni
SMSilvia Maitz
Silvia Maitz
MIMaria Iascone
Maria Iascone
RBRaffaele Badolato
Raffaele Badolato

15 September 2023 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
LDLaura Dotta
Laura Dotta
GBGiulia Baresi
Giulia Baresi
NTNicola Tamassia
Nicola Tamassia
FCFederica Calzetti
Federica Calzetti
FBFrancisco Bianchetto‐Aguilera
Francisco Bianchetto‐Aguilera
RBRaffaele Badolato
Raffaele Badolato